SCHEMBL23937779

SCHEMBL23937779

CNC(=O)c1nn(O)c2ncsc12

nearest known ligand 0.35

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CNOT7 Q9UIV1 1/20 0.34
TP53 P04637 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
BAZ2B Q9UIF8 1/20 0.33
YTHDC1 Q96MU7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21958535 0.81 CNOT7 (0.33) CNOT7
SCHEMBL21958537 0.78 MAP3K14 (0.38) CNOT7
SCHEMBL23937842 0.76 BAZ2B (0.32) TP53SMN1; SMN2BAZ2B
SCHEMBL21955857 0.73 FEN1 (0.37) TP53SMN1; SMN2BAZ2BYTHDC1
SCHEMBL13485303 0.68 NAMPT (0.53) YTHDC1
SCHEMBL20631037 0.68 KMT2A (0.38)
SCHEMBL21958542 0.68 ADORA3 (0.34) TP53SMN1; SMN2BAZ2BYTHDC1
SCHEMBL1231822 0.67 CFTR (0.36) YTHDC1
SCHEMBL18337793 0.67 CFTR (0.36) YTHDC1
SCHEMBL21958625 0.67 ERCC1 (0.36) TP53SMN1; SMN2BAZ2BYTHDC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3399968-B1 SELECTIVE INHIBITORS OF CLINICALLY IMPORTANT MUTANTS OF THE EGFR TYROSINE KINASE CS PHARMATECH LTD (KY) 2021-10-20 EP disclosed